| Sample |
TM (%) |
PM (%) |
VAP |
VSL |
VCL |
ALH |
BCF |
STR |
LIN |
|
RT Control |
88 ± 2.0 |
71 ± 2.6a |
149 ± 9.6 |
137 ± 9.3 |
178 ± 6.7 |
4.1 ± 0.3a |
28 ± 1.8a |
89 ± 0.9a |
75 ± 3.2a |
Incubated |
81 ± 4.7 |
63 ± 6.6a,b |
154 ± 13.7 |
145 ± 13.0 |
172 ± 12.9 |
3.2 ± 0.2b |
28 ± 1.2a |
91 ± 1.5a |
79 ± 4.0a |
Capacitated |
77 ± 5.4 |
53 ± 6.7b |
135 ± 15.3 |
118 ± 14.5 |
186 ± 14.6 |
5.9 ± 0.3c |
34 ± 1.04b |
85 ± 1.1b |
61 ± 3.2b |
|
| *Mean values (± SEM) with different superscripts within columns
(a,b,c) are statistically different (P < .05). |
Conditions for the room temperature (RT) control were as follows:
Hepes-BWW plus 1 mg/mL BSA. |
Conditions for the 37°C samples were as follows: incubated group,
Bicarb-BWW plus 30 mg/mL BSA; and capacitated group, Bicarb-BWW plus 30 mg/mL
BSA, final 30 minutes with 1.2 mmol/L dbcAMP and 1 mmol/L caffeine. |
|